Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Common Equity (2010 - 2026)

Updated

Corcept Therapeutics' Common Equity was $705.78 million in Q2 2026, up 11.0% from $635.79 million a year earlier and up 10.6% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Common Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Corcept Therapeutics came in at $647.81 million, down 4.7% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
  • In earlier years, Common Equity was $679.59 million in FY2024 (+34.1%), $506.71 million in FY2023 (+1.0%), $501.84 million in FY2022 (+33.5%) and $375.81 million in FY2021 (-28.2%).
  • The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2010.
  • Compared with a year earlier, Common Equity was higher in five of the last eight quarters, with growth averaging 12.8%.
  • The best year-over-year quarter for Common Equity over five years was Q2 2024 (growth of 41.4%); the worst was Q4 2021 (a decline of 28.2%).
  • Per Business Quant data, CORT's Common Equity in the three quarters before Q2 2026 was $637.99 million (Q1 2026), $647.81 million (Q4 2025) and $631.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 705.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 705.78 Mn
Mar 31, 2026 637.99 Mn
Dec 31, 2025 647.81 Mn
Sep 30, 2025 631.90 Mn
Jun 30, 2025 635.79 Mn
Mar 31, 2025 683.29 Mn
Dec 31, 2024 679.59 Mn
Sep 30, 2024 638.84 Mn
Jun 30, 2024 596.24 Mn
Mar 31, 2024 547.86 Mn
Dec 31, 2023 506.71 Mn
Sep 30, 2023 461.68 Mn
Jun 30, 2023 421.61 Mn
Mar 31, 2023 529.58 Mn
Dec 31, 2022 501.84 Mn
Sep 30, 2022 473.36 Mn
Jun 30, 2022 442.33 Mn
Mar 31, 2022 407.81 Mn
Dec 31, 2021 375.81 Mn
Sep 30, 2021 540.23 Mn
API Access

Corcept Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CORT&period=max&api_key=YOUR_API_KEY